Navigation Links
Tengion Provides Business Update and Reports Second Quarter 2013 Financial Results
Date:8/14/2013

man patients, as well as to assess the safety and preliminary efficacy of the Neo-Urinary Conduit.

Neo-Kidney Augment Program Update
The Neo-Kidney Augment is Tengion's second clinical program and is being developed with the goal of using a patient's own kidney cells to augment or replace renal function for patients with chronic kidney disease (CKD) who are rapidly progressing toward end stage renal disease (ESRD). The Neo-Kidney Augment is intended to prevent or delay the need for dialysis or kidney transplant by catalyzing the regeneration of functional kidney tissue in patients with ESRD.

In April 2013, Tengion announced the acceptance of the Company's Clinical Trial Application filed with the Medical Products Agency in Sweden to initiate a Phase 1 clinical trial to evaluate the safety and delivery of the Neo-Kidney Augment, in patients with CKD. The Company plans to enroll up to five patients in the Phase 1 trial in 2013 and will follow each patient for up to two years. The trial will involve delivery of an active regenerative dose of Neo-Kidney Augment in patients with CKD. The Company plans to initiate a Phase 1 trial in the U.S. during the fourth quarter of 2013 to evaluate the Company's Neo-Kidney Augment in patients with CKD.

Recent Corporate Highlights
In June 2013, Tengion closed transactions totaling $33.6 million, including a strategic investment from Celgene Corporation in the form of a $15 million payment in cash. Celgene was granted right of first negotiation on the Neo-Kidney Augment program and also the exclusive option to acquire the assets required for development of a neo-esophageal implant. Celgene also received warrants to purchase shares of Tengion common stock. Additionally, the Company completed a private placement of $18.6 million aggregate principal amount of Senior Secured Convertible Notes and warrants to both new and existing investors.

Second Quarter Financial Update
For the second quarter ended
'/>"/>

SOURCE Tengion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Tengion Reports Second Quarter 2012 Financial Results
2. Tengion to Present at the BIO CEO & Investor Conference
3. Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
4. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
7. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
8. Elevate Provides Remote Access to Personal Health Records Using MyMedicalRecords.com
9. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
10. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
11. Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Changan Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... The issue: In consultation with ... (lot 710535) of Clavulin-400 (70mL) after receiving a complaint from ... one bottle of the  product. No other lots of GSK ... is an oral antibiotic used in adults and children aged ... comes as a powder in bottles and is mixed with ...
(Date:4/17/2015)... , April 17, 2015  Regulatory leaders in ... released bipartisan discussion draft called "21 st Century ... planned to be taken up by Congress soon and ... and medical device products are developed and marketed in ... reason, many companies have begun to consider how the ...
(Date:4/17/2015)... Ill. , April 17, 2015  AbbVie Inc. ("AbbVie") ... announced that it has extended the expiration of its exchange ... stock of Pharmacyclics, Inc. to 5 p.m., New ... On April 17, 2015, AbbVie also voluntarily withdrew ... Improvements Act in order to provide the FTC with additional ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 221st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4
(Date:4/18/2015)... 2015 The Residential Senior Care ... past five years. The industry, which provides residential and ... fully care for themselves, has boomed on account of ... care for seniors with memory impairment. As a result, ... rate of 4.1% to $1.9 billion over the five ...
(Date:4/18/2015)... 18, 2015 Carinsurancesavings.biz has released a ... are cheaper during Spring. , Spring can ... plan. Drivers should make sure they compare the newest ... Clients can learn more about Spring car insurance offers ... Auto insurance quotes are becoming more and more popular. ...
(Date:4/18/2015)... April 18, 2015 "I wanted ... to create a healthful juice that contained essential ... Rosedale, Md. "It increases my energy, improves skin ... , He developed Tapp's Juice to contain fruits, ... to prevent physical and mental fatigue. It features ...
(Date:4/18/2015)... 18, 2015 Lowcostcarinsuranceprice.com has released a ... have on auto insurance prices . , ... of vehicle theft may have to pay more for ... auto insurance policies can also offer protection against vehicle ... be compared online on a single website: http://lowcostcarinsuranceprice.com/ ...
(Date:4/18/2015)... York, New York (PRWEB) April 18, 2015 ... ) filed on behalf of individuals who were ... replacement system continue to move forward in the U.S. ... Order dated April 10th, the Court has amended an ... of unrelated cases. Among other things, the new amendment ...
Breaking Medicine News(10 mins):Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3
... Quick Patient-Information Retrieval From Multiple Medical ... Dec. 14 AT&T Inc. (NYSE: ... Ltd. (JOHA) has,awarded AT&T a three-year contract ... to other network solutions. Continuing its relationship,as ...
... Lancet Oncology publication provides important insights on the ... Test in clinical practice -, AMSTERDAM, The ... MammaPrint(R) breast cancer prognosis test was,successfully implemented in ... hospitals in The Netherlands. MammaPrint(R) assigned,up to one- ...
... in the last several decades, but at least one advance ... rise in women in prevalence, morbidity and mortality. By 2000, ... of men. But the rising number of cases in women ... apparent gender-bias. , The disease expression of COPD in women ...
... CHICAGO, Dec. 13 Advanced Life Sciences,Holdings, Inc. ... in the,discovery, development and commercialization of novel drugs ... today announced,that it completed its private placement of ... warrants to purchase approximately 5.1,million shares of common ...
... Hologic, Inc.,(Nasdaq: HOLX ) announced today ... recommended that the pre-market application for,Adiana(R) Permanent Contraception ... decision by a vote of 10 to 3., ... but traditionally follows the,recommendations of its advisory panels. ...
... a scandal now ensnaring,some of the nations leading ... Wal-Mart, Costco, Target, Safeway, and Wild Oats of ... legal filings in federal courts in Seattle, Denver, ... heels of class action,lawsuits against Aurora Dairy Corporation, ...
Cached Medicine News:Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 2Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 3Health News:Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen 2Health News:Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen 3Health News:When disease discriminates: Women and COPD 2Health News:When disease discriminates: Women and COPD 3Health News:Advanced Life Sciences Completes Private Placement for $20 Million 2Health News:Advanced Life Sciences Completes Private Placement for $20 Million 3Health News:FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable 2Health News:FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable 3Health News:FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable 4Health News:Nation's Largest Retailers Accused of Organic Fraud 2
MISTY OX® Gas Injection Nebulizer (GIN)...
... been developing diverse medical products ... Our medical-surgical products have earned ... quality and customer satisfaction. Graham-Fields ... Labtron® line of diagnostic instruments, ...
Reliable and Affordable. The Schuco 3000 Nebulizer by Allied has been designed to offer a compact style that provides worry-free affordable nebulizer therapy....
... HOPE continuous nebulizer is improved CNBT technology, which ... remixing SVNs every 15 minutes. HOPE allows you ... eight hours. Heliox administration couldn't be easier, with ... of Heliox, you can turn the HOPE nebulizer ...
Medicine Products: